Participants included researchers, scientific leaders, women scientists, and private sector representatives, reflecting the diversity of Ghana’s research community.
The agreement brings together BoomRay’s expertise in radioligand therapy development and Novartis’ global capabilities in radiopharmaceutical research and commercialisation.
In its new publication, WHO Guidelines on Expanding Contraceptive Options, WHO provides countries with evidence-based recommendations to broaden access to contraceptive methods and offer more flexibility in how people use them.
The collaboration will assess selected targets for several therapeutic approaches, including antibody-drug conjugates (ADCs), multispecific antibodies and T cell engagers (TcEs).
The National Adolescent Sexual and Reproductive Health and Rights (SRHR) and Nutrition Strategy 2026 to 2031 was unveiled at the Ministry of Health in Monrovia.
The procedures included 352 cardiac surgeries, 14 aortic procedures, 90 thoracic surgeries, seven endovascular aortic aneurysm repairs (EVAR) and 38 other procedures.
The designation recognises the hospitals’ specialised capabilities in breast cancer diagnosis and treatment, including multidisciplinary care, advanced technologies, clinical research and patient support.
The facility can produce starting materials, drug substances and drug products using customised processes as well as technology transferred from established manufacturing platforms.
Organisers expect more than 16 national regulatory authorities and notified bodies, alongside more than 100 speakers and 450 decision makers from over 25 countries.
The project will cover Cameroon, Chad, Mali, Niger and Nigeria, combining water, sanitation and hygiene (WASH) interventions with disease surveillance and medical support.